These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 16891570)
21. Cortisol awakening response in adolescents with acute sexual abuse related posttraumatic stress disorder. Keeshin BR; Strawn JR; Out D; Granger DA; Putnam FW Depress Anxiety; 2014 Feb; 31(2):107-14. PubMed ID: 23893710 [TBL] [Abstract][Full Text] [Related]
22. Prospective Study of the Effectiveness of Paroxetine on the Onset of Posttraumatic Stress Disorder, Depression, and Health and Functional Outcomes After Trauma. Borrelli J; Starr A; Downs DL; North CS J Orthop Trauma; 2019 Feb; 33(2):e58-e63. PubMed ID: 30277987 [TBL] [Abstract][Full Text] [Related]
23. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Rasmusson AM; Lipschitz DS; Wang S; Hu S; Vojvoda D; Bremner JD; Southwick SM; Charney DS Biol Psychiatry; 2001 Dec; 50(12):965-77. PubMed ID: 11750893 [TBL] [Abstract][Full Text] [Related]
24. Blunted salivary and plasma cortisol response in patients with panic disorder under psychosocial stress. Petrowski K; Wintermann GB; Schaarschmidt M; Bornstein SR; Kirschbaum C Int J Psychophysiol; 2013 Apr; 88(1):35-9. PubMed ID: 23313605 [TBL] [Abstract][Full Text] [Related]
25. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder. Ruhé HG; Khoenkhoen SJ; Ottenhof KW; Koeter MW; Mocking RJ; Schene AH Psychoneuroendocrinology; 2015 Feb; 52():261-71. PubMed ID: 25544738 [TBL] [Abstract][Full Text] [Related]
26. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Tucker P; Ruwe WD; Masters B; Parker DE; Hossain A; Trautman RP; Wyatt DB Biol Psychiatry; 2004 Jul; 56(2):121-8. PubMed ID: 15231444 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular responses to an acute psychological stressor are associated with the cortisol awakening response in individuals with chronic neck pain. Shahidi B; Sannes T; Laudenslager M; Maluf KS Physiol Behav; 2015 Oct; 150():93-8. PubMed ID: 25662023 [TBL] [Abstract][Full Text] [Related]
28. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Schneier FR; Neria Y; Pavlicova M; Hembree E; Suh EJ; Amsel L; Marshall RD Am J Psychiatry; 2012 Jan; 169(1):80-8. PubMed ID: 21908494 [TBL] [Abstract][Full Text] [Related]
29. Paroxetine treatment, following behavioral suppression of PTSD-like symptoms in mice, prevents relapse by activating the infralimbic cortex. Bentefour Y; Rakibi Y; Bennis M; Ba-M'hamed S; Garcia R Eur Neuropsychopharmacol; 2016 Feb; 26(2):195-207. PubMed ID: 26706692 [TBL] [Abstract][Full Text] [Related]
30. Salivary cortisol among American Indians with and without posttraumatic stress disorder (PTSD): gender and alcohol influences. Laudenslager ML; Noonan C; Jacobsen C; Goldberg J; Buchwald D; Bremner JD; Vaccarino V; Manson SM Brain Behav Immun; 2009 Jul; 23(5):658-62. PubMed ID: 19146946 [TBL] [Abstract][Full Text] [Related]
31. The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression-A randomised trial. Knorr U; Vinberg M; Gether U; Winkel P; Gluud C; Wetterslev J; Kessing LV Psychiatry Res; 2012 Dec; 200(2-3):354-60. PubMed ID: 22703642 [TBL] [Abstract][Full Text] [Related]
33. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. Weber-Hamann B; Gilles M; Lederbogen F; Heuser I; Deuschle M J Clin Psychiatry; 2006 Dec; 67(12):1856-61. PubMed ID: 17194262 [TBL] [Abstract][Full Text] [Related]
34. Lower cortisol levels and attenuated cortisol reactivity to daily-life stressors in adults with 22q11.2 deletion syndrome. van Duin EDA; Vaessen T; Kasanova Z; Viechtbauer W; Reininghaus U; Saalbrink P; Vingerhoets C; Hernaus D; Booij J; Swillen A; Vorstman J; van Amelsvoort T; Myin-Germeys I Psychoneuroendocrinology; 2019 Aug; 106():85-94. PubMed ID: 30959234 [TBL] [Abstract][Full Text] [Related]
35. Pretreatment cortisol predicts trauma-focused psychotherapy response in youth with (partial) posttraumatic stress disorder. Zantvoord JB; Ensink JBM; Op den Kelder R; Wessel AMA; Lok A; Lindauer RJL Psychoneuroendocrinology; 2019 Nov; 109():104380. PubMed ID: 31352130 [TBL] [Abstract][Full Text] [Related]
36. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Marshall RD; Lewis-Fernandez R; Blanco C; Simpson HB; Lin SH; Vermes D; Garcia W; Schneier F; Neria Y; Sanchez-Lacay A; Liebowitz MR Depress Anxiety; 2007; 24(2):77-84. PubMed ID: 16892419 [TBL] [Abstract][Full Text] [Related]
37. Salivary cortisol and cardiovascular activity during stress in oppositional-defiant disorder boys and normal controls. van Goozen SH; Matthys W; Cohen-Kettenis PT; Gispen-de Wied C; Wiegant VM; van Engeland H Biol Psychiatry; 1998 Apr; 43(7):531-9. PubMed ID: 9547933 [TBL] [Abstract][Full Text] [Related]
38. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Vermetten E; Vythilingam M; Southwick SM; Charney DS; Bremner JD Biol Psychiatry; 2003 Oct; 54(7):693-702. PubMed ID: 14512209 [TBL] [Abstract][Full Text] [Related]
39. Changes in Salivary Cortisol During Psychotherapy for Posttraumatic Stress Disorder: A Pilot Study in 30 Veterans. Rauch SAM; King AP; Liberzon I; Sripada RK J Clin Psychiatry; 2017 May; 78(5):599-603. PubMed ID: 28102979 [TBL] [Abstract][Full Text] [Related]
40. Paroxetine in the treatment of post traumatic stress disorder: our experiences. Kucukalić A; Bravo-Mehmedbasić A; Dzubur-Kulenović A Bosn J Basic Med Sci; 2008 Feb; 8(1):76-9. PubMed ID: 18318677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]